As diabetes care continues to be a crucial focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable evolution in incretin mimetic medications. While all https://thebookmarkking.com/story22080798/the-new-drug-vs-tirzepatid-vs-semaglutide-a-head-to-head-look